Galmed Pharma (GLMD) Reports Q1 EPS of $0.17

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of $0.17, versus $0.17 reported last year.

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight